tiprankstipranks
Trending News
More News >
Wuhan General Group [China] (WUHN)
OTHER OTC:WUHN

Wuhan General Group [China] (WUHN) Price & Analysis

Compare
25 Followers

WUHN Stock Chart & Stats

$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)

WUHN FAQ

What was Wuhan General Group [China]’s price range in the past 12 months?
Wuhan General Group [China] lowest stock price was <$0.01 and its highest was $0.51 in the past 12 months.
    What is Wuhan General Group [China]’s market cap?
    Wuhan General Group [China]’s market cap is $19.22K.
      When is Wuhan General Group [China]’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Wuhan General Group [China]’s earnings last quarter?
      Currently, no data Available
      Is Wuhan General Group [China] overvalued?
      According to Wall Street analysts Wuhan General Group [China]’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Wuhan General Group [China] pay dividends?
        Wuhan General Group [China] does not currently pay dividends.
        What is Wuhan General Group [China]’s EPS estimate?
        Wuhan General Group [China]’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Wuhan General Group [China] have?
        Wuhan General Group [China] has 48,055,160 shares outstanding.
          What happened to Wuhan General Group [China]’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Wuhan General Group [China]?
          Currently, no hedge funds are holding shares in WUHN
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Wuhan General Group [China]

            Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
            Similar Stocks
            Company
            Price & Change
            Follow
            Biodexa Pharmaceuticals
            Nuwellis
            Scinai Immunotherapeutics
            Oragenics

            Ownership Overview

            <0.01%100.00%
            Insiders
            Mutual Funds
            <0.01% Other Institutional Investors
            100.00% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks